Global Payments heads into its May 6 Q1 2026 earnings call with a notable and accelerating build in short positioning — the clearest tension shaping sentiment ahead of the release.
Short sellers have moved decisively in recent weeks. SI as a percentage of the free float climbed from roughly 4.0% in mid-March to 6.1% by April 30, a 27% rise over the past month. The move accelerated sharply last week — up 17% in a single week — with the absolute share count crossing 14 million for the first time in the 30-day window. Yet the borrow market remains relaxed. Cost to borrow is just 0.42% annually, down 12% over the week, and borrow availability has not tightened in the way that would suggest a building squeeze dynamic. The ORTEX short score has drifted higher too, moving from around 40 to 44 over the past fortnight, though it remains well below the levels that historically flag extreme bearish conviction. Availability data also confirms there is no scarcity in the lending pool. Short sellers are adding positions, but on loose terms.
The rally tells a different story. The stock gained 7% last week and is up another 7.5% over the past month, closing at $72.36 and sitting around 25% below the consensus mean price target of ~$96. That gap is the central bull argument: analysts broadly see room to recover, and forward EPS estimates rank in the 97th percentile for year-on-year growth. Options positioning is calm — the put/call ratio at 0.48 is barely above its 20-day average of 0.46, with a z-score of just 0.75, showing no unusual demand for downside protection ahead of the print.
The bear case is harder to dismiss, however. Analyst activity over the past several weeks has run consistently negative. Truist trimmed its target to $81 while keeping a Hold rating. RBC cut from $97 to $82. Citigroup, still rated Buy, sliced its target from $110 to $90. Raymond James stepped back to Market Perform from Outperform. The direction is clear: the Street still sees upside from current prices, but conviction in the recovery narrative has faded. The core concern is sluggish top-line momentum — net revenue growth of just 1% year-on-year weighed down by non-core market exits and FX headwinds — alongside questions over whether EvoSynergy integration is translating into the margin expansion promised when the Evo acquisition closed. Bulls point to the back-half pipeline, improving card volumes in Issuer Solutions, and at least $200 million in targeted revenue synergies through cross-selling. The debate is less about direction and more about timing.
One ownership detail stands out. GTCR LLC, the private equity firm that structured the Evo transaction, holds roughly 16% of shares outstanding — a block large enough to anchor the register and limit circulating supply. Insider activity in the 90-day window has been dominated by executive sales clustered on February 27, including the CEO, CFO, and COO, all selling at prices around $76, above where the stock trades today. The net insider position over 90 days was positive in share count terms due to awards, but the pattern of executive disposals at higher prices than the current level is worth noting.
Wednesday's print is therefore a test of whether Global Payments can demonstrate that revenue growth is inflecting — not just stabilising — and whether the EvoSynergy margin story is on track to meet the second-half targets the company needs to close the gap to analyst price levels.
See the live data behind this article on ORTEX.
Open GPN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
